BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 31720937)

  • 1. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study.
    Zhang KP; Zhang X; Zhang Q; Ruan GT; Song MM; Xie HL; Zhang HY; Li XR; Yang M; Liu YY; Li QQ; Ge YZ; Liu XY; Lin SQ; Li W; Xu HX; Deng L; Shi HP
    J Nutr Health Aging; 2022; 26(9):847-855. PubMed ID: 36156676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers in cardiac syndrome X: a systematic review and meta-analysis.
    Zhao Y; Ghaedi A; Azami P; Nabipoorashrafi SA; Drissi HB; Dezfouli MA; Sarejloo S; Lucke-Wold B; Cerillo J; Khanzadeh M; Jafari N; Khanzadeh S
    BMC Cardiovasc Disord; 2024 May; 24(1):276. PubMed ID: 38807048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Systemic Inflammatory Response, Complication Severity, and Survival Following Surgery for Colorectal Cancer.
    McSorley ST; Watt DG; Horgan PG; McMillan DC
    Ann Surg Oncol; 2016 Sep; 23(9):2832-40. PubMed ID: 27016295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
    Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38538400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).
    Wang QL; Ma C; Yuan C; Shi Q; Wolpin BM; Zhang Y; Fuchs CS; Meyer J; Zemla T; Cheng E; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi S; Goldberg RM; Venook A; Blanke C; Shields AF; O'Reilly EM; Meyerhardt JA; Ng K
    Clin Cancer Res; 2023 Jul; 29(14):2621-2630. PubMed ID: 37289007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    Int J Gen Med; 2024; 17():997-1005. PubMed ID: 38505146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
    Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
    Am Surg; 2024 Apr; ():31348241248693. PubMed ID: 38644521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 Investigation.
    Meyer-Knees JW; Falkenthal J; Geisel D; Neumann CCM; Hilfenhaus G; Stephan LU; Schöning W; Malinka T; Pratschke J; Stintzing S; Pelzer U
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nutritional index and postoperative outcomes in patients with colon cancer after laparoscopic surgery.
    Tominaga T; Nagasaki T; Akiyoshi T; Fukunaga Y; Honma S; Nagaoka T; Matsui S; Minami H; Miyanari S; Yamaguchi T; Ueno M
    Surg Today; 2020 Dec; 50(12):1633-1643. PubMed ID: 32556551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
    Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of laparoscopic vs open right hemicolectomy for colon cancer: A propensity score matching analysis of the Japanese National Clinical Database.
    Matsuda T; Endo H; Inomata M; Hasegawa H; Kumamaru H; Miyata H; Sakai Y; Kakeji Y; Kitagawa Y; Watanabe M
    Ann Gastroenterol Surg; 2020 Nov; 4(6):693-700. PubMed ID: 33319160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Akiyoshi T; Gotoh O; Tanaka N; Kiyotani K; Yamamoto N; Ueno M; Fukunaga Y; Mori S
    Cancer Immunol Immunother; 2021 Feb; 70(2):509-518. PubMed ID: 32845355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for outlet obstruction after laparoscopic surgery and diverting ileostomy for rectal cancer.
    Sasaki S; Nagasaki T; Oba K; Akiyoshi T; Mukai T; Yamaguchi T; Fukunaga Y; Fujimoto Y
    Surg Today; 2021 Mar; 51(3):366-373. PubMed ID: 32754842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence.
    Murahashi S; Akiyoshi T; Sano T; Fukunaga Y; Noda T; Ueno M; Zembutsu H
    Br J Cancer; 2020 Sep; 123(5):803-810. PubMed ID: 32565539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic multivisceral resection for locally advanced colon cancer: a single-center analysis of short- and long-term outcomes.
    Mukai T; Nagasaki T; Akiyoshi T; Fukunaga Y; Yamaguchi T; Konishi T; Nagayama S; Ueno M
    Surg Today; 2020 Sep; 50(9):1024-1031. PubMed ID: 32152770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic and robotic lateral lymph node dissection for rectal cancer.
    Nakanishi R; Yamaguchi T; Akiyoshi T; Nagasaki T; Nagayama S; Mukai T; Ueno M; Fukunaga Y; Konishi T
    Surg Today; 2020 Mar; 50(3):209-216. PubMed ID: 31989237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.